Company news from the 04/24/07 news brief
Novartis has acquired the rights to a late-stage cancer drug from UK firm Antisoma.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.